Chemoinformaics analysis of 8-AZABICYCLO[3.2.1]OCTAN-3-YL 3,4-DIMETHOXYBENZOATE
| Molecular Weight | 291.347 | nRot | 4 |
| Heavy Atom Molecular Weight | 270.179 | nRig | 16 |
| Exact Molecular Weight | 291.147 | nRing | 3 |
| Solubility: LogS | -2.6 | nHRing | 2 |
| Solubility: LogP | 2.255 | No. of Aliphatic Rings | 2 |
| Acid Count | 0 | No. of Aromatic Rings | 1 |
| Base Count | 1 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 42 | No. of Aliphatic Hetero Cycles | 2 |
| No. of Heavy Atom | 21 | No. of Aromatic Carbocycles | 1 |
| nHetero | 5 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 2 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 21 | No. of Saturated Hetero Cycles | 2 |
| No. of Carbon atom | 16 | No. of Saturated Rings | 2 |
| No. of Nitrogen atom | 1 | No. of Arom Atom | 6 |
| No. of Oxygen atom | 4 | No. of Arom Bond | 6 |
| nHA | 5 | APOL | 45.0307 |
| nHD | 1 | BPOL | 27.7133 |
| QED | 0.861 |
| Synth | 3.686 |
| Natural Product Likeliness | 0.685 |
| NR-PPAR-gamma | 0.024 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.123 |
| Pgp-sub | 0.385 |
| HIA | 0.007 |
| CACO-2 | -4.63 |
| MDCK | 0.0000259 |
| BBB | 0.401 |
| PPB | 0.282611 |
| VDSS | 2.439 |
| FU | 0.453102 |
| CYP1A2-inh | 0.212 |
| CYP1A2-sub | 0.836 |
| CYP2c19-inh | 0.719 |
| CYP2c19-sub | 0.787 |
| CYP2c9-inh | 0.096 |
| CYP2c9-sub | 0.469 |
| CYP2d6-inh | 0.599 |
| CYP2d6-sub | 0.885 |
| CYP3a4-inh | 0.21 |
| CYP3a4-sub | 0.408 |
| CL | 8.473 |
| T12 | 0.766 |
| hERG | 0.862 |
| Ames | 0.014 |
| ROA | 0.053 |
| SkinSen | 0.387 |
| Carcinogencity | 0.107 |
| EI | 0.015 |
| Respiratory | 0.924 |
| NR-Aromatase | 0.01 |
| Antiviral | Yes |
| Prediction | 0.82456 |